|Videos|November 24, 2016

Future Applications of Immunotherapy

Marcos Pires, PhD, assistant professor at Lehigh University, discusses future applications of immunotherapy.

Marcos Pires, PhD, assistant professor at Lehigh University, discusses future applications of immunotherapy.

Interview Transcript (slightly modified for readability)

“I think, if anything, the great success immunotherapies against cancer is teaching us, is that there’s no reason to believe that [immunotherapy] can’t be evaluated for a number of diseases, where you have cells or pathogens you’d like to remove from the system. It will probably be the case that there is a version of an agent or a therapy that can go after bacteria. I imagine the same can be true for viruses, [and] perhaps for fungal infections as well.

It’s unclear if there’s a real limit [to what illnesses immunotherapies can fight], because after all, if you think about what it’s doing, it’s just strengthening a protective feature that we have already.”


Related to this article

The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.
FAQ: XDR Shigella
Here is some important information around this pathogen and the intestinal infection.